Where Winds Meet‘s Update 1.2 represents a major systems and content expansion rather than a simple content drop. The patch combines three pillars: new narrative arcs (Kaifeng Campaign, Lost Chapters) ...

Players can expect ZZZ 2.5, To Be Fuel for the Night, to come out on December 29, 2025, 10:00 PM ET (UTC-5). Keep in mind that certain time zones will gain access to version 2.5 from December 30 ...

Despite OpenAI's bold claims of widespread improvements, GPT-5.2 feels largely the same as the model it replaces. Google, meanwhile, delivers a more substantial Gemini 3 update. I’ve been writing ...

$2.5M supports a secure upper-middle-class retirement at 4% withdrawal ($100K annually) but requires discipline and planning. An income-first portfolio split across dividend stocks, bonds and REITs ...

OpenAI launched its latest frontier model, GPT-5.2, on Thursday amid increasing competition from Google, pitching it as its most advanced model yet and one designed for developers and everyday ...

Imagine having a tool that doesn’t just understand your words but also interprets your images, deciphers your data, and even assists with coding, all in one seamless platform. That’s the promise of ...

Exciting times once again as we near the release of the next pair of Dispatch episodes. We are already halfway through the release schedule, which means, after the release of Episodes 5 and 6, we will ...

From turbo power to upgraded tech, find out if the 2025 Mazda CX-5 2.5 Turbo Premium delivers enough value over the base 2.5 S trim.

It was a great week in this spot last week for everything but the touchdown props! We'll take that, even if it's not as fun to miss the guys who score the points. We're going to pivot and go back to ...

Jalen Hurts and the Eagles didn't complete a pass last week in the second half against the Buccaneers. Getty Images Gambling content 21+. The New York Post may receive an affiliate commission if you ...

In a randomized trial, low-dose oral minoxidil at 2.5 mg/d showed comparable hair density gains to 5 mg/d dosing in men with androgenetic alopecia (AGA), with fewer adverse events. Researchers ...